Dennis Karl Huang
EVP, Chief Technical Operations Officer · Ultragenyx Pharmaceutical Inc.
- 2026
- Apr 20, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Dennis Karl Huang files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Emil D. Kakkis - $1.24M in RARE purchases and sales in the last 12 months
- Howard Horn - $1.08M in RARE purchases and sales in the last 12 months
- Karah Herdman Parschauer - $488K in RARE purchases and sales in the last 12 months
- Erik Harris - $240K in RARE purchases and sales in the last 12 months
- John Richard Pinion - $229K in RARE purchases and sales in the last 12 months
- Eric Crombez - $169K in RARE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Dennis Karl Huang?
Dennis Karl Huang is a corporate insider, tracked as EVP, Chief Technical Operations Officer of Ultragenyx Pharmaceutical Inc. (RARE). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Dennis Karl Huang last file a Form 4?
The most recent primary Form 4 on record is dated 20 April 2026, one of 2 filings going back to 2026.